Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 12, 2022

Total Value: $215M (100.0% shares, 0.0% debt)

Holdings (25)

— AMRYT PHARMA PLC - SPNR ADR 20.5%
Value $44.02M Shares 6,298,348 Share Price $6.99 Est. Cost/Share $12.42 Unrealized @ Report Date —
— CTI BIOPHARMA CORP 10.2%
Value $21.98M Shares 3,681,195 Share Price $5.97 Est. Cost/Share $2.49 Unrealized @ Report Date —
XERS XERIS BIOPHARMA HOLDINGS INC 8.3%
Value $17.94M Shares 11,647,417 Share Price $1.54 * Est. Cost/Share $2.20 Unrealized @ Report Date -4.0%
ADMA ADMA BIOLOGICS INC 6.4%
Value $13.86M Shares 7,000,000 Share Price $1.98 Est. Cost/Share $1.31 Unrealized @ Report Date +49.7%
— AMARIN CORP PLC -ADR 6.1%
Value $13.19M Shares 8,853,763 Share Price $1.49 Est. Cost/Share $2.49 Unrealized @ Report Date —
QDEL QUIDELORTHO CORP 5.4%
Value $11.64M Shares 119,787 Share Price $97.18 * Est. Cost/Share $101.94 Unrealized @ Report Date 0.0%
RZLT REZOLUTE INC 4.5%
Value $9.696M Shares 3,001,926 Share Price $3.23 * Est. Cost/Share $3.95 Unrealized @ Report Date -15.9%
— OPTINOSE INC 4.5%
Value $9.576M Shares 2,616,515 Share Price $3.66 Est. Cost/Share $1.62 Unrealized @ Report Date —
URGN UROGEN PHARMA LTD 4.2%
Value $9.099M Shares 1,111,050 Share Price $8.19 * Est. Cost/Share $7.09 Unrealized @ Report Date -3.2%
LGND LIGAND PHARMACEUTICALS 4.2%
Value $8.944M Shares 100,244 Share Price $89.22 * Est. Cost/Share $68.37 Unrealized @ Report Date -17.0%
— AFFIMED NV 4.1%
Value $8.708M Shares 3,143,773 Share Price $2.77 Est. Cost/Share $2.77 Unrealized @ Report Date —
— APOLLO ENDOSURGERY INC 3.7%
Value $7.891M Shares 2,161,999 Share Price $3.65 Est. Cost/Share $5.27 Unrealized @ Report Date —
OVID OVID THERAPEUTICS INC 3.5%
Value $7.499M Shares 3,487,928 Share Price $2.15 * Est. Cost/Share $3.43 Unrealized @ Report Date -29.5%
XGN EXAGEN INC 3.4%
Value $7.235M Shares 1,260,387 Share Price $5.74 Est. Cost/Share $11.52 Unrealized @ Report Date -49.4%
CSTL CASTLE BIOSCIENCES INC 3.0%
Value $6.483M Shares 295,372 Share Price $21.95 * Est. Cost/Share $23.24 Unrealized @ Report Date 0.0%
— CONFORMIS INC 2.8%
Value $6.122M Shares 17,304,350 Share Price $0.35 Est. Cost/Share $0.75 Unrealized @ Report Date —
DMAC DIAMEDICA THERAPEUTICS INC 1.1%
Value $2.376M Shares 1,176,344 Share Price $2.02 * Est. Cost/Share $4.07 Unrealized @ Report Date -42.7%
— AERIE PHARMACEUTICALS INC 0.9%
Value $1.884M Shares 251,235 Share Price $7.50 Est. Cost/Share $8.10 Unrealized @ Report Date —
— OPIANT PHARMACEUTICALS INC 0.8%
Value $1.826M Shares 152,278 Share Price $11.99 Est. Cost/Share $11.99 Unrealized @ Report Date —
ATYR ATYR PHARMA INC 0.8%
Value $1.702M Shares 601,580 Share Price $2.83 * Est. Cost/Share $6.39 Unrealized @ Report Date -43.5%
— MARINUS PHARMACEUTICALS INC 0.5%
Value $1.173M Shares 242,327 Share Price $4.84 Est. Cost/Share $5.90 Unrealized @ Report Date —
XOMA XOMA CORP 0.5%
Value $1.023M Shares 45,910 Share Price $22.28 * Est. Cost/Share $20.30 Unrealized @ Report Date +1.1%
ANIP ANI PHARMACEUTICALS INC 0.4%
Value $854K Shares 28,800 Share Price $29.65 * Est. Cost/Share $41.63 Unrealized @ Report Date -30.7%
— SYNLOGIC INC 0.0%
Value $107K Shares 92,746 Share Price $1.15 Est. Cost/Share $3.01 Unrealized @ Report Date —
— CIDARA THERAPEUTICS INC 0.0%
Value $102K Shares 208,443 Share Price $0.49 Est. Cost/Share $1.47 Unrealized @ Report Date —